RSV and Flu H5 Vaccine Formulations Study
Part of Infections, Lungs & breathing clinical trials.
This study tests different versions of experimental vaccines designed to protect against RSV (a common respiratory virus) and flu H5. You'll receive one of these vaccines and be monitored to see how safe it is and how your body responds.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 49 years old
- If you are a woman who can become pregnant, you must use reliable birth control or not have sex for the entire study (from 4 weeks before your first vaccine until 12 weeks after your last vaccine)
- If you are a woman, you cannot be pregnant or breastfeeding
- You do not have any medical conditions that would make it unsafe for you to participate, in the doctor's judgment
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new vaccine against respiratory syncytial virus (RSV), a common virus that can cause lung infections. It is for healthy adults aged 18 and older, to see if the vaccine is safe and produces a good immune response.
This trial tests an experimental vaccine against respiratory syncytial virus (RSV) in children who are at high risk of serious RSV illness due to chronic medical conditions or weakened immune systems. The goal is to see if the vaccine is safe and effective in preventing RSV-related lower respiratory tract infections.
This trial tests a new RSV vaccine for people aged 60 and above. RSV is a common virus that can cause serious breathing problems in older adults. The study will see if the vaccine is safe and helps protect you from RSV.
This study tests a new RSV vaccine called YKYY025 in healthy adults. The main goal is to see if it is safe and to measure how the immune system responds.
This study tests an RSV vaccine in adults aged 18 and older, especially those with chronic health issues like heart or lung disease. It aims to see how safe and effective the vaccine is at preventing RSV infections.
This study tests a new vaccine that may protect babies from a common breathing virus called RSV. It is given to healthy women to see if it is safe and if it helps the body make protection that could be passed to a baby during pregnancy.
Hear when a new Respiratory Syncytial Virus (RSV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.